For specialists

Depressive and dysthymic disorders in psychosomatic pathology and the ways of their pharmacological correction
Published in the journal «Practitioner» № 2’2015
Peculiarities of anemia' treatment in chronic yuvenile abnormal uterine bleeding
Published in the journal “Obstetrics. Gynecology. Genetics” № 2'2015
The effect of taking the combined remedy Protecta on the pain syndrome in patients with primary osteoarthritis of the knee and hip joint
Department of Orthopedics and Traumatology, P.L. Shupyk National Medical University of Ukraine '2015
Comparative characteristics of the drug protecta with the intravenous hondroprotektorami
Published in the journal «Family Medicine» № 4 (54)’2014
The use of Polyjen in the complex treatment of patients with respiratory impairment of smell
Published in the journal «Family Medicine» № 3 (53)’2014
Possibilities of using WORLD MEDICINE drugs in complex pharmacological support of cataract surgery
Published in a journal «Ophthalmological Journal» № 4’2013
Comparison of the effect of topical application of dexamethasone and diclofenac on the process of corneal epithelialization after a burn
Published in the journal «Ophthalmology Journal» № 3’2013
Comparative analysis of the effect of physiotherapy methods on pain syndrome in patients with dorsalgia at the outpatient-polyclinic stage of treatment
Published in a journal «Medical hydrology and rehabilitation» № 2’2013
Clinical and pathogenetic relationship of autonomic and myofascial dysfunction (assessment of the effectiveness of the drug Cocarnit)
Published in a journal «International neurological journal» № 1(55) ’2013
The use of omega-3 polyunsaturated fatty acids in clinical dermatology
Published in the journal «Ukrainian Journal of Dermatology, Venereology, Cosmetology» № 1(48)’2013

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design